Kaida BioPharma Inc. — Form D
Kaida BioPharma Inc. of FORT LAUDERDALE, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-14. The offering totals $4K, of which $4K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-06-14
- Form: D
- Accession: 0001731122-23-001124
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4K
- Amount sold: $4K
- Investors: 47
- Date of first sale: 2023-06-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-484191
Issuer
- Name: Kaida BioPharma Inc.
- CIK: 0001973954
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 416 SW 1ST AVENUE, FORT LAUDERDALE, FL, 33301
- Phone: (917) 683-3092
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Stephen Dunn | Director | Fort Lauderdale, FL |
| Craig Pierson | Director | Fort Lauderdale, FL |
| Craig Pierson | Executive Officer | Fort Lauderdale, FL |
| Stella Vnook | Director | Kenmore, NY |
Other filings by this issuer (1)
More